Observational study / 1978
A retrospective review found six responses among 68 Laetrile treatment courses, providing no definite conclusions supporting its anti-cancer activity.
The National Cancer Institute solicited cases showing objective benefit from Laetrile treatment, receiving 93 cases despite an estimated 70,000 Americans having used it. After eliminating 26 cases due to insufficient documentation and adding conventionally treated cases, a blinded panel of 12 oncologists evaluated 160 courses of treatment (68 Laetrile, 68 chemotherapy, 24 'no treatment') from 93 patients. The panel judged six Laetrile courses to have produced a response, including two complete and four partial responses. The authors concluded these results allow no definite conclusions supporting the anti-cancer activity of Laetrile.
Shows an association, not proof of cause and effect.
- Study type
- Retrospective case analysis with blinded panel review
- Who was studied
- Abstracted records of 93 patients evaluating 160 treatment courses
- What was measured
- Objective cancer response
THE PAPER
Special report on Laetrile: the NCI Laetrile Review. Results of the National Cancer Institute's retrospective Laetrile analysis.
Ellison NM, Byar DP, Newell GR. N Engl J Med, 1978.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.